The Peptide Drug Conjugates (PDCs) Market was valued at USD 3.75 billion in 2024 and is projected to reach USD 26.23 billion by 2035, growing at a CAGR of approximately 19.34% between 2025 and 2035. PDCs involve the fusion of drugs with peptide-based therapies to enable targeted delivery, offering a more effective treatment option for various diseases, particularly cancer. By leveragi... https://www.metatechinsights.com/industry-insights/peptide-drug-conjugates-market-2461